In this compelling episode of the “Wait, but Why” series, Keith Wright sits down with Mapillar Dahn, Founder and CEO of MTS Sickle Cell Foundation. Mapillar discusses the critical issue of sickle cell disease, its impact on patients, and the importance of clinical trials in advancing treatment. She shares her expert insights on improving community engagement, offering strategies for effectively navigating the clinical trial process. With a focus on patient advocacy and research, this episode sheds light on the challenges faced by those affected by sickle cell disease and explores ways to enhance support and participation in clinical trials. This conversation is essential viewing for anyone interested in patient advocacy, clinical research, and community engagement in the context of sickle cell disease.